The board of directors at Ambys Medicines consists of experienced professionals in the fields of healthcare and business. The president and CEO of MOMA Therapeutics, as well as directors from Phathom Pharmaceuticals and Akaza Bioscience, make up the board. Furthermore, the head of the Gastroenterology Therapeutic Area Unit at Takeda also has a seat on the board. With such a wealth of experience and knowledge between them, the board is able to provide Ambys Medicines with critical insights into the ever-changing landscape of the healthcare industry.
View all